- Home
- VERV vs GCO Comparison
VERV vs GCO Comparison
Compare VERV & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- GCO
- Stock Information
- Founded
- VERV 2018
- GCO 1924
- Country
- VERV United States
- GCO United States
- Employees
- VERV N/A
- GCO N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- GCO Clothing/Shoe/Accessory Stores
- Sector
- VERV Health Care
- GCO Consumer Discretionary
- Exchange
- VERV Nasdaq
- GCO Nasdaq
- Market Cap
- VERV 475.0M
- GCO 493.6M
- IPO Year
- VERV 2021
- GCO N/A
- Fundamental
- Price
- VERV $5.50
- GCO $42.61
- Analyst Decision
- VERV Strong Buy
- GCO Hold
- Analyst Count
- VERV 4
- GCO 1
- Target Price
- VERV $25.75
- GCO $31.00
- AVG Volume (30 Days)
- VERV 1.6M
- GCO 191.1K
- Earning Date
- VERV 11-05-2024
- GCO 12-06-2024
- Dividend Yield
- VERV N/A
- GCO N/A
- EPS Growth
- VERV N/A
- GCO N/A
- EPS
- VERV N/A
- GCO N/A
- Revenue
- VERV $24,396,000.00
- GCO $2,318,063,000.00
- Revenue This Year
- VERV $97.47
- GCO $0.58
- Revenue Next Year
- VERV N/A
- GCO $10.86
- P/E Ratio
- VERV N/A
- GCO N/A
- Revenue Growth
- VERV 219.91
- GCO 0.32
- 52 Week Low
- VERV $4.31
- GCO $23.21
- 52 Week High
- VERV $19.34
- GCO $44.34
- Technical
- Relative Strength Index (RSI)
- VERV 44.33
- GCO 75.28
- Support Level
- VERV $5.19
- GCO $42.03
- Resistance Level
- VERV $7.40
- GCO $44.10
- Average True Range (ATR)
- VERV 0.65
- GCO 2.23
- MACD
- VERV -0.12
- GCO 0.34
- Stochastic Oscillator
- VERV 7.88
- GCO 90.91
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.
About GCO Genesco Inc.
Genesco Inc sells footwear, headwear, sports apparel, and accessories. The company has four reportable segments namely Journeys Group, derives maximum revenue which comprised of Journeys, Journeys Kidz, and Little Burgundy retail footwear chains, e-commerce operations, and catalog. Its Schuh Group is comprised of the Schuh retail footwear chain and e-commerce operations. The Johnston & Murphy Group is comprised of Johnston & Murphy retail operations, e-commerce operations, and catalog and wholesale distribution of products under the Johnston & Murphy and Genesco Brands Group. Licensed Brands, comprised of Dockers Footwear, under a license from Levi Strauss & Company.